It is described the case of a 74-years-old woman with probable Alzheimer Disease who showed good clinical response to rivastigmine associated with relevant improvement of cerebral perfusion after 1 year of treatment. The single-photon emission computed tomography (SPECT) scan showed a significant improvement in cortical uptake of the tracer in temporo-parietal and frontal regions in comparison to the examination performed before the treatment.
Journal article
2015-01-01T00:00:00+00:00
50
188 - 191
3
Aged, Alzheimer Disease, Brain, Cerebrovascular Circulation, Cholinesterase Inhibitors, Female, Humans, Predictive Value of Tests, Rivastigmine, Sensitivity and Specificity, Tomography, Emission-Computed, Single-Photon, Treatment Outcome